Clinicopathological Factors and Interleukin-6 Levels Associated With Low Relative Dose Intensity in Women With Breast Cancer Receiving First-Line Chemotherapy
The proportion of BC patients receiving a low chemotherapy RDI in our study was comparable to published literature and drove close monitoring of patients at risk to provide adequate management.
Authors
- Johan Kurnianda (ORCID: https://orcid.org/0000-0002-2045-1795)
- Yufi Kartika Astari (ORCID: https://orcid.org/0000-0003-0999-8826)
- Raden Bowo Pramono
- Kartika Widayati Taroeno‐Hariadi (ORCID: https://orcid.org/0000-0002-7791-9010)
- Susanna Hilda Hutajulu (ORCID: https://orcid.org/0000-0001-9236-9435)
- Meita Ucche (ORCID: https://orcid.org/0000-0001-5260-3119)
- Rizka Humardewayanti Asdie (ORCID: https://orcid.org/0000-0002-9707-5839)
- Riani Witaningrum
- Ibnu Purwanto (ORCID: https://orcid.org/0000-0002-2246-4813)
- Mardiah Suci Hardianti (ORCID: https://orcid.org/0000-0002-5360-6693)
- Dewi Kartikawati Paramita
Institutions
- Universitas Gadjah Mada (ID)
- Rumah Sakit Umum Pusat Dr. Sardjito (ID)
Publication Details
- Journal
- World Journal of Oncology
- Published
- 2024-12-01
- DOI
- https://doi.org/10.14740/wjon1954
- Citations
- 2
- Primary Topic
- Cancer survivorship and care
- Type
- article
- Field-Weighted Citation Impact
- 0.57